Topiramate Curbs Binge Eating, Obesity

FEBRUARY 01, 2005
Susan Farley

The epilepsy drug topiramate may provide long-term benefits for people with binge-eating disorder and obesity, as suggested by results of a small study from the University of Cincinnati College of Medicine. The study included 61 subjects randomly selected to receive topiramate or placebo; 44 patients received topiramate, and results were available for 43 of these patients, who reached an ending dosage of 250 mg/d. All 43 patients experienced a significant decline in the number of weekly binge-eating episodes, and they experienced a significant weight loss as well. Based on these results, the study team concluded that further studies of topiramate for the long-term treatment of binge-eating disorder are needed.

Ms. Farley is a freelance medical writer based in Wakefield, RI.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.